Radiotranscriptomics signature-based predictive nomograms for radiotherapy response in patients with nonsmall cell lung cancer: Combination and association of CT features and serum miRNAs levels.
Liyuan FanQiang CaoXiuping DingDongni GaoQiwei YangBaosheng LiPublished in: Cancer medicine (2020)
The radiotranscriptomics signature could be an independent biomarker for evaluating radiotherapeutic responses in patients with NSCLC. The radiotranscriptomics signature-based nomogram could be used to predict patients' ORR, which would represent progress in individualized medicine.
Keyphrases
- end stage renal disease
- ejection fraction
- small cell lung cancer
- newly diagnosed
- chronic kidney disease
- early stage
- single cell
- computed tomography
- radiation therapy
- prognostic factors
- peritoneal dialysis
- magnetic resonance imaging
- squamous cell carcinoma
- cell therapy
- stem cells
- lymph node metastasis
- advanced non small cell lung cancer
- patient reported outcomes
- image quality
- dual energy